Post by Ilias Gissis

The Urgent Search for a Cure for COVID-19 CureVac (Germany): packs the "building instructions" for the coat protein of SARS-CoV-2 in nanoparticles, which deliver the mRNA into the cells. The cells then form the coat protein and present it on their surface, whereupon the immune system is mobilized. Janssen (daughter of Johnson & Johnson, USA): uses its technologies (AdVac and PER.C6) that were already used in the production of its Ebola vaccine, which is currently used in the Congo and in Rwanda. BioNTech + Pfizer (Germany, USA): mRNA-based vaccine candidate. Clinical testing expected in late April. Sanofi Pasteur (France): uses the company's technology platform for recombinant DNA. Moderna + NIAID (USA): RNA vaccine. NIH's Vaccine Research Center has started Phase I. Inovio + Wistar Institute (USA) Clover Biopharmaceuticals (China) Novavax (USA) Tonix Pharmaceuticals (USA) is modifying a Horsepox virus for its TNX-1800 vaccine. Altimmune (USA #vaccine #viruses #kardiohirourgos #biotechnology #pneumonia #covid19